Global Next Generation Tissue Biomarkers Market Report 2025

Item added to cart!

Published : December 2025

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF

Purchase This Report

Next Generation Tissue Biomarkers Global Market Report 2025

Name: Next Generation Tissue Biomarkers Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Type (Genomic Biomarkers, Proteomic Biomarkers, Epigenetic Biomarkers, Transcriptomic Biomarkers, Metabolomic Biomarkers), By Technology (Immunohistochemistry, Next-Generation Sequencing, Mass Spectrometry (Ms)-Based Proteomics, Spatial Biology Platforms, Digital Pathology And Artificial Intelligence Analysis, Other Technologies), By Application (Oncology, Companion Diagnostics, Drug Discovery And Development, Neurology, Other Applications), By End Use (Hospitals And Reference Labs, Pharma And Biotech Companies, Academic And Research Institutes, Contract Research Organizations) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Next Generation Tissue Biomarkers Market Overview

• Next Generation Tissue Biomarkers market size has reached to $2.68 billion in 2024

• Expected to grow to $4.89 billion in 2029 at a compound annual growth rate (CAGR) of 12.7%

• Growth Driver: Rising Demand For Personalized Medicine Driving Growth In The Market Due To Advancements In Genomic Technologies And Increasing FDA Approvals

• Market Trend: Advancements In Genomic Technologies Enhancing Precision And Efficiency In Cancer Diagnostics And Treatment

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Next Generation Tissue Biomarkers Market?

Next generation tissue biomarkers are advanced biological indicators obtained from tissue samples that allow for more detailed and accurate analysis of biological conditions. They reflect subtle molecular and cellular changes within tissues, helping to better understand various physiological and pathological processes. These biomarkers are identified through refined analytical approaches that enable a deeper examination of tissue characteristics.

The main types of next generation tissue biomarkers are Genomic Biomarkers, proteomic biomarkers, epigenetic biomarkers, transcriptomic biomarkers, and metabolomic biomarkers. Genomic biomarkers are deoxyribonucleic acid- or ribonucleic acid-based indicators used to detect, diagnose, or predict disease risk and treatment response by analyzing genetic mutations or expression patterns. The technologies supporting these biomarkers include immunohistochemistry, next-generation sequencing, mass spectrometry-based proteomics, spatial biology platforms, digital pathology integrated with artificial intelligence, and others. The biomarkers are applied across areas such as oncology, companion diagnostics, drug discovery and development, neurology, and others, and are utilized by end users including hospitals and reference laboratories, pharmaceutical and biotechnology firms, academic and research institutes, and contract research organizations.

Next Generation Tissue Biomarkers Market Size and growth rate 2025 to 2029: Graph

What Is The Next Generation Tissue Biomarkers Market Size 2025 And Growth Rate?

What Is The Next Generation Tissue Biomarkers Market Growth Forecast?

The next generation tissue biomarkers market size is expected to see rapid growth in the next few years. It will grow to $4.89 billion in 2029 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to growing demand for multiplex biomarker assays, rising use of next-generation sequencing, increasing investment in cancer research, expanding applications of digital pathology, growing use of AI in diagnostics, a surge in clinical trials for targeted therapies, and increasing availability of tissue-based genomic data. Major trends in the forecast period include advancements in next-generation sequencing, integration of artificial intelligence (AI) in digital pathology, development of advanced mass spectrometry-based proteomics, advancements in ribonucleic acid biomarker detection technologies, and integration with cloud-based data platforms.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Next Generation Tissue Biomarkers Market Segmented?

1) By Type: Genomic Biomarkers, Proteomic Biomarkers, Epigenetic Biomarkers, Transcriptomic Biomarkers, Metabolomic Biomarkers

2) By Technology: Immunohistochemistry, Next-Generation Sequencing, Mass Spectrometry (Ms)-Based Proteomics, Spatial Biology Platforms, Digital Pathology And Artificial Intelligence Analysis, Other Technologies

3) By Application: Oncology, Companion Diagnostics, Drug Discovery And Development, Neurology, Other Applications

4) By End Use: Hospitals And Reference Labs, Pharma And Biotech Companies, Academic And Research Institutes, Contract Research Organizations

Subsegments:

1) By Genomic Biomarkers: Single Nucleotide Polymorphisms, Copy Number Variations, Gene Fusions

2) By Proteomic Biomarkers: Protein Expression Levels, Post-Translational Modifications, Protein-Protein Interactions

3) By Epigenetic Biomarkers: Histone Modification Patterns, Chromatin Remodeling Biomarkers, Non-Coding Ribonucleic Acid Regulation

4) By Transcriptomic Biomarkers: Long Non-Coding Ribonucleic Acids, Circular Ribonucleic Acids, Alternative Splicing Variants

5) By Metabolomic Biomarkers: Lipid Profiles, Amino Acid Signatures, Organic Acids

What Is Driving The Next Generation Tissue Biomarkers Market? Rising Demand For Personalized Medicine Driving Growth In The Market Due To Advancements In Genomic Technologies And Increasing FDA Approvals

The rising demand for personalized medicine is expected to propel the growth of the next generation tissue biomarkers market going forward. Personalized medicine is a medical approach that tailors treatment based on an individual's genetic makeup, lifestyle, and environmental factors. The adoption of personalized medicine is increasing due to continuous advancements in genomic technologies, as they allow for highly specific and individualized treatment strategies. The demand for personalized medicine is boosting the development of next-generation tissue biomarkers, as they provide precise and individualized information needed to tailor treatments to each patient's unique tissue profile. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. The newly approved personalized treatments for 2023 also include seven cancer drugs and three for other diseases and conditions. Therefore, the rising demand for personalized medicine is driving the growth of the next generation tissue biomarkers industry.

Who Are The Major Players In The Global Next Generation Tissue Biomarkers Market?

Major companies operating in the next generation tissue biomarkers market are Roche Diagnostics, Thermo Fisher Scientific Inc., LabCorp., Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corporation, Myriad Genetics Inc., NeoGenomics Laboratories Inc., Guardant Health Inc., Foundation Medicine Inc., NanoString Technologies Inc., PathAI Inc., Biocartis Group NV, Personalis Inc., Ultivue Inc., Indica Labs Inc., Strata Oncology Inc., Genialis Inc., Alida Biosciences Inc., and Biofidelity Ltd.

What Are The Key Trends Of The Global Next Generation Tissue Biomarkers Market? Advancements In Genomic Technologies Enhancing Precision And Efficiency In Cancer Diagnostics And Treatment

Major companies operating in the next generation tissue biomarkers market are focusing on developing advanced solutions, such as genomic-based diagnostic assays and sequencing solutions, to enhance the accuracy, speed, and personalization of cancer diagnosis and treatment. Genomic-based diagnostic assays and sequencing solutions refer to tools and techniques that examine genetic information to identify disease-related biomarkers, enabling more precise and personalized approaches to diagnosis and therapy. For instance, in August 2024, Illumina Inc., a US-based biotechnology company, received FDA approval for its TruSight Oncology Comprehensive test, along with two companion diagnostics, to rapidly match cancer patients to targeted therapies. The test profiles over 500 genes from a single tissue sample, enabling precise treatment selection for various solid tumors. It automates biomarker detection and supports 24/7 deployment, significantly reducing turnaround times and enhancing clinical efficiency, representing a modern approach to streamlining cancer diagnostics within a regulated framework.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Next Generation Tissue Biomarkers Market? Quanterix Acquires Akoya Biosciences To Forge Integrated Tissue-To-Blood Biomarker Platform

In July 2025, Quanterix Corporation, a US-based life sciences company, acquired Akoya Biosciences Inc. for an undisclosed amount. With this acquisition, Quanterix Corporation aims to integrate Akoya’s spatial biology capabilities into its existing blood-based biomarker platform, thereby enhancing its technological depth and bolstering its position in tissue-to-blood precision diagnostics. Akoya Biosciences Inc. is a US-based life sciences technology company that provides solutions for analyzing next generation tissue biomarkers.

What Is The Regional Outlook For The Global Next Generation Tissue Biomarkers Market?

North America was the largest region in the next generation tissue biomarkers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Next Generation Tissue Biomarkers Market?

The next generation tissue biomarkers market consists of revenues earned by entities by providing services such as epigenomics analysis, single-cell analysis, and multiplex immunofluorescence. The market value includes the value of related goods sold by the service provider or included within the service offering. The next generation tissue biomarkers market also includes sales of diagnostic assays, reagents and antibodies, sequencing kits, imaging and staining systems, multiplex analysis platforms, and spatial biology instruments. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Next Generation Tissue Biomarkers Industry?

The next generation tissue biomarkers market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the next generation tissue biomarkers industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Next Generation Tissue Biomarkers Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$3.03 billion
Revenue Forecast In 2034	$4.89 billion
Growth Rate	CAGR of 12.7% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	Type, Technology, Application, End Use
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Roche Diagnostics, Thermo Fisher Scientific Inc., LabCorp., Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corporation, Myriad Genetics Inc., NeoGenomics Laboratories Inc., Guardant Health Inc., Foundation Medicine Inc., NanoString Technologies Inc., PathAI Inc., Biocartis Group NV, Personalis Inc., Ultivue Inc., Indica Labs Inc., Strata Oncology Inc., Genialis Inc., Alida Biosciences Inc., and Biofidelity Ltd.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Next Generation Tissue Biomarkers Market Characteristics

3. Next Generation Tissue Biomarkers Market Trends And Strategies

4. Next Generation Tissue Biomarkers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Next Generation Tissue Biomarkers Growth Analysis And Strategic Analysis Framework

5.1. Global Next Generation Tissue Biomarkers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Next Generation Tissue Biomarkers Market Growth Rate Analysis

5.4. Global Next Generation Tissue Biomarkers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Next Generation Tissue Biomarkers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Next Generation Tissue Biomarkers Total Addressable Market (TAM)

6. Next Generation Tissue Biomarkers Market Segmentation

6.1. Global Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Genomic Biomarkers

Proteomic Biomarkers

Epigenetic Biomarkers

Transcriptomic Biomarkers

Metabolomic Biomarkers

6.2. Global Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Immunohistochemistry

Next-Generation Sequencing

Mass Spectrometry (Ms)-Based Proteomics

Spatial Biology Platforms

Digital Pathology And Artificial Intelligence Analysis

Other Technologys

6.3. Global Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oncology

Companion Diagnostics

Drug Discovery And Development

Neurology

Other Applications

6.4. Global Next Generation Tissue Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Reference Labs

Pharma And Biotech Companies

Academic And Research Institutes

Contract Research Organizations

6.5. Global Next Generation Tissue Biomarkers Market, Sub-Segmentation Of Genomic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Single Nucleotide Polymorphisms (Snps)

Copy Number Variations (Cnvs)

Gene Fusions

6.6. Global Next Generation Tissue Biomarkers Market, Sub-Segmentation Of Proteomic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Protein Expression Levels

Post-Translational Modifications (Ptms)

Protein-Protein Interactions

6.7. Global Next Generation Tissue Biomarkers Market, Sub-Segmentation Of Epigenetic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Histone Modification Patterns

Chromatin Remodeling Biomarkers

Non-Coding Ribonucleic Acid Regulation

6.8. Global Next Generation Tissue Biomarkers Market, Sub-Segmentation Of Transcriptomic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Long Non-Coding Ribonucleic Acids

Circular Ribonucleic Acids

Alternative Splicing Variants

6.9. Global Next Generation Tissue Biomarkers Market, Sub-Segmentation Of Metabolomic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Lipid Profiles

Amino Acid Signatures

Organic Acids

7. Next Generation Tissue Biomarkers Market Regional And Country Analysis

7.1. Global Next Generation Tissue Biomarkers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Next Generation Tissue Biomarkers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Next Generation Tissue Biomarkers Market

8.1. Asia-Pacific Next Generation Tissue Biomarkers Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Next Generation Tissue Biomarkers Market

9.1. China Next Generation Tissue Biomarkers Market Overview

9.2. China Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Next Generation Tissue Biomarkers Market

10.1. India Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Next Generation Tissue Biomarkers Market

11.1. Japan Next Generation Tissue Biomarkers Market Overview

11.2. Japan Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Next Generation Tissue Biomarkers Market

12.1. Australia Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Next Generation Tissue Biomarkers Market

13.1. Indonesia Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Next Generation Tissue Biomarkers Market

14.1. South Korea Next Generation Tissue Biomarkers Market Overview

14.2. South Korea Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Next Generation Tissue Biomarkers Market

15.1. Western Europe Next Generation Tissue Biomarkers Market Overview

15.2. Western Europe Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Next Generation Tissue Biomarkers Market

16.1. UK Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Next Generation Tissue Biomarkers Market

17.1. Germany Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Next Generation Tissue Biomarkers Market

18.1. France Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Next Generation Tissue Biomarkers Market

19.1. Italy Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Next Generation Tissue Biomarkers Market

20.1. Spain Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Next Generation Tissue Biomarkers Market

21.1. Eastern Europe Next Generation Tissue Biomarkers Market Overview

21.2. Eastern Europe Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Next Generation Tissue Biomarkers Market

22.1. Russia Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Next Generation Tissue Biomarkers Market

23.1. North America Next Generation Tissue Biomarkers Market Overview

23.2. North America Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Next Generation Tissue Biomarkers Market

24.1. USA Next Generation Tissue Biomarkers Market Overview

24.2. USA Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Next Generation Tissue Biomarkers Market

25.1. Canada Next Generation Tissue Biomarkers Market Overview

25.2. Canada Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Next Generation Tissue Biomarkers Market

26.1. South America Next Generation Tissue Biomarkers Market Overview

26.2. South America Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Next Generation Tissue Biomarkers Market

27.1. Brazil Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Next Generation Tissue Biomarkers Market

28.1. Middle East Next Generation Tissue Biomarkers Market Overview

28.2. Middle East Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Next Generation Tissue Biomarkers Market

29.1. Africa Next Generation Tissue Biomarkers Market Overview

29.2. Africa Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Next Generation Tissue Biomarkers Market Competitive Landscape And Company Profiles

30.1. Next Generation Tissue Biomarkers Market Competitive Landscape

30.2. Next Generation Tissue Biomarkers Market Company Profiles

30.2.1. Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. LabCorp. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Next Generation Tissue Biomarkers Market Other Major And Innovative Companies

31.1. Illumina Inc.

31.2. Bio-Rad Laboratories Inc.

31.3. QIAGEN N.V.

31.4. Bio-Techne Corporation

31.5. Myriad Genetics Inc.

31.6. NeoGenomics Laboratories Inc.

31.7. Guardant Health Inc.

31.8. Foundation Medicine Inc.

31.9. NanoString Technologies Inc.

31.10. PathAI Inc.

31.11. Biocartis Group NV

31.12. Personalis Inc.

31.13. Ultivue Inc.

31.14. Indica Labs Inc.

31.15. Strata Oncology Inc.

32. Global Next Generation Tissue Biomarkers Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Next Generation Tissue Biomarkers Market

34. Recent Developments In The Next Generation Tissue Biomarkers Market

35. Next Generation Tissue Biomarkers Market High Potential Countries, Segments and Strategies

35.1 Next Generation Tissue Biomarkers Market In 2029 - Countries Offering Most New Opportunities

35.2 Next Generation Tissue Biomarkers Market In 2029 - Segments Offering Most New Opportunities

35.3 Next Generation Tissue Biomarkers Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Next Generation Tissue Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Next Generation Tissue Biomarkers Market, Sub-Segmentation Of Genomic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Next Generation Tissue Biomarkers Market, Sub-Segmentation Of Proteomic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Next Generation Tissue Biomarkers Market, Sub-Segmentation Of Epigenetic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Next Generation Tissue Biomarkers Market, Sub-Segmentation Of Transcriptomic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Next Generation Tissue Biomarkers Market, Sub-Segmentation Of Metabolomic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Next Generation Tissue Biomarkers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Next Generation Tissue Biomarkers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Roche Diagnostics Financial Performance

Table 81: Thermo Fisher Scientific Inc. Financial Performance

Table 82: LabCorp. Financial Performance

Table 83: Quest Diagnostics Incorporated Financial Performance

Table 84: Agilent Technologies Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Next Generation Tissue Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Next Generation Tissue Biomarkers Market, Sub-Segmentation Of Genomic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Next Generation Tissue Biomarkers Market, Sub-Segmentation Of Proteomic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Next Generation Tissue Biomarkers Market, Sub-Segmentation Of Epigenetic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Next Generation Tissue Biomarkers Market, Sub-Segmentation Of Transcriptomic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Next Generation Tissue Biomarkers Market, Sub-Segmentation Of Metabolomic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Next Generation Tissue Biomarkers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Next Generation Tissue Biomarkers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Next Generation Tissue Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Next Generation Tissue Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Next Generation Tissue Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Roche Diagnostics Financial Performance

Figure 81: Thermo Fisher Scientific Inc. Financial Performance

Figure 82: LabCorp. Financial Performance

Figure 83: Quest Diagnostics Incorporated Financial Performance

Figure 84: Agilent Technologies Inc. Financial Performance

2025 Over-The-Counter (OTC) Diet Products Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Parathyroid Disease Treatment Market Revenue Outlook: Strategic Insights and Forecast to 2029

Industry Forecast: PCSK9 Inhibitor Market to Generate $6.87 Billion Revenue by 2029

CAGR of 5.4% Projected for Pediatric Asthma Treatment Market From 2025 to 2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the MSI-H and DMMR Market with 2025 insights from The Business Research Company.

Nail Salon Global Market Report 2025 – By Service (Manicure, Pedicure, Fiberglass And Silk Wraps, UV Gel Overlays And Extensions, Acrylic Overlays And Extensions), By Customer Preference (Luxury Experience, Budget-Friend...

Nail Polish Global Market Report 2025 – By Product Type (Gel, Matte, Pearl, Other Products), By Distribution Channel (Supermarkets/Hypermarkets, Online Channels, Traditional Stores, Exclusive Beauty Specialist Stores, Ot...

Smart Pneumatics Global Market Report 2025 – By Component (Hardware, Software, Services), By Distribution Channel (Direct, Indirect), By Industry (Oil And Gas, Energy And Power, Water And Wastewater, Automotive, Semicond...

Pneumatic Components And Systems Global Market Report 2025 – By Type (Pneumatic Valve, Pneumatic Cylinder, Pneumatic Gripper, Pressure Sensor, Pressure Switch, Auxiliary Components, Other Types), By Capacity (Light Duty,...

Automotive Piston Global Market Report 2025 – By Piston Type (Trunk Piston, Crosshead Piston, Slipper Piston, Deflector Piston), By Component Type (Piston, Piston Rings, Piston Pin), By Coating Type (Oil Shedding, Dry Fi...

High-Pressure Processing Equipment Global Market Report 2025 – By Orientation Type (Horizontal, Vertical), By Vessel Volume (Less Than 100 Liter, 100-500 Liter, More Than 500 Liter), By Application (Tolling, Juices And B...

Steel Piston Global Market Report 2025 - By Component (Piston Head, Piston Ring, Piston Pin), By Shape (Flat Top Piston, Bowl Piston, Dome Piston), By Coating (Dry Film Lubricant, Thermal Barriers, Oil Shedding Coatings)...

Frequently Asked Questions

What is the definition of the Next Generation Tissue Biomarkers market?

How will the Next Generation Tissue Biomarkers market drivers and restraints affect the market dynamics? What forces will shape the Next Generation Tissue Biomarkers industry going forward?

The market major growth driver - Rising Demand For Personalized Medicine Driving Growth In The Market Due To Advancements In Genomic Technologies And Increasing FDA Approvals. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Next Generation Tissue Biomarkers market?

The next generation tissue biomarkers market size has grown rapidly in recent years. It will grow from $2.68 billion in 2024 to $3.03 billion in 2025 at a compound annual growth rate (CAGR) of 13.1%. The growth in the historic period can be attributed to rising demand for personalized medicine, increasing adoption of immunohistochemistry techniques, growing need for early disease detection, increasing healthcare spending, rise in diagnostic imaging technologies, rising awareness about biomarker-based diagnostics, and growing focus on companion diagnostics. The next generation tissue biomarkers market size is expected to see rapid growth in the next few years. It will grow to $4.89 billion in 2029 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to growing demand for multiplex biomarker assays, rising use of next-generation sequencing, increasing investment in cancer research, expanding applications of digital pathology, growing use of AI in diagnostics, a surge in clinical trials for targeted therapies, and increasing availability of tissue-based genomic data. Major trends in the forecast period include advancements in next-generation sequencing, integration of artificial intelligence (AI) in digital pathology, development of advanced mass spectrometry-based proteomics, advancements in ribonucleic acid biomarker detection technologies, and integration with cloud-based data platforms. For further insights on this market, request a sample here

How is the Next Generation Tissue Biomarkers market segmented?

The next generation tissue biomarkers market covered in this report is segmented
1) By Type: Genomic Biomarkers, Proteomic Biomarkers, Epigenetic Biomarkers, Transcriptomic Biomarkers, Metabolomic Biomarkers
2) By Technology: Immunohistochemistry, Next-Generation Sequencing, Mass Spectrometry (Ms)-Based Proteomics, Spatial Biology Platforms, Digital Pathology And Artificial Intelligence Analysis, Other Technologies
3) By Application: Oncology, Companion Diagnostics, Drug Discovery And Development, Neurology, Other Applications
4) By End Use: Hospitals And Reference Labs, Pharma And Biotech Companies, Academic And Research Institutes, Contract Research Organizations Subsegments:
1) By Genomic Biomarkers: Single Nucleotide Polymorphisms, Copy Number Variations, Gene Fusions
2) By Proteomic Biomarkers: Protein Expression Levels, Post-Translational Modifications, Protein-Protein Interactions
3) By Epigenetic Biomarkers: Histone Modification Patterns, Chromatin Remodeling Biomarkers, Non-Coding Ribonucleic Acid Regulation
4) By Transcriptomic Biomarkers: Long Non-Coding Ribonucleic Acids, Circular Ribonucleic Acids, Alternative Splicing Variants
5) By Metabolomic Biomarkers: Lipid Profiles, Amino Acid Signatures, Organic Acids For further insights on this market, request a sample here

Which region has the largest share of the Next Generation Tissue Biomarkers market? What are the other regions covered in the report?

North America was the largest region in the next generation tissue biomarkers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next generation tissue biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Next Generation Tissue Biomarkers market?

What are the key trends in the Next Generation Tissue Biomarkers market?

Major trends in this market include Advancements In Genomic Technologies Enhancing Precision And Efficiency In Cancer Diagnostics And Treatment. For further insights on this market, request a sample here.